Drug intelligence / Profile preview

agrostis stolonifera pollen

Development stage
Unknown
Lead developer
ALK Abelló
Administration
Subcutaneous, Intradermal, Percutaneous
01

Overview

Agrostis stolonifera pollen is a biologic allergenic extract derived from the pollen of Agrostis stolonifera, commonly known as creeping bentgrass. Approved by the FDA in 1967 under BLA 101376, this extract is used for both the diagnosis of grass pollen hypersensitivity via skin testing and the treatment of allergic conditions through allergen immunotherapy. The therapeutic mechanism involves the induction of immunological tolerance, characterized by a shift from a Th2-mediated allergic response to a Th1-mediated or regulatory T-cell response, alongside the production of allergen-specific IgG4 blocking antibodies. This process reduces the IgE-mediated release of inflammatory mediators from mast cells and basophils upon subsequent allergen exposure, providing long-term relief for patients with allergic rhinitis, conjunctivitis, and asthma.

Brand names
Creeping Bentgrass Pollen Extract
Other names
Agrostis stolonifera extractCreeping bentgrass pollen
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on agrostis stolonifera pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on agrostis stolonifera pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call